Literature DB >> 2052301

Ocular inflammation in Crohn's disease.

J F Salmon1, J P Wright, A D Murray.   

Abstract

During a 4-year period, the authors examined 19 patients with Crohn's disease and associated ocular inflammation. Seven patients had uveitis, eight had episcleritis, and four had anterior scleritis. Large peripheral corneal infiltrates developed in two patients with scleritis. Increased bowel activity was closely related to the presence of acute episcleritis but not to uveitis or scleritis. To determine risk factors for the development of ocular inflammation, this group of 19 patients was compared with a group of 93 patients with Crohn's disease in whom ocular inflammation was not present. There were no demographic differences between the groups. Patients with colitis or ileocolitis were more likely to suffer from ocular inflammation (23.9%, 17 of 71), than patients with small bowel involvement alone (2.8%, 1 of 36) (P = 0.013). Those with arthritis or arthralgia had a higher incidence of ocular inflammation (29.4%, 15 of 51), than patients without joint involvement (6.6%, 4 of 61) (P = 0.003). These results suggest that the risk of developing ocular inflammation in Crohn's disease may be related to the site of bowel involvement and to the presence of arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052301     DOI: 10.1016/s0161-6420(91)32268-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

Review 1.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

2.  pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis.

Authors:  L K Gordon; M Eggena; G N Holland; J M Weisz; J Braun
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

3.  Prevalence of subclinical anterior uveitis in adult patients with inflammatory bowel disease.

Authors:  F D Verbraak; M C Schreinemachers; A Tiller; S J van Deventer; M D de Smet
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

4.  Conjunctival granulomatosis in a patient with ulcerative colitis.

Authors:  S A G Rogers; A G Tyers
Journal:  Eye (Lond)       Date:  2013-01-18       Impact factor: 3.775

5.  The prevalence of ocular involvement in patients with inflammatory bowel disease.

Authors:  Safiye Yilmaz; Ebru Aydemir; Ahmet Maden; Belkis Unsal
Journal:  Int J Colorectal Dis       Date:  2007-01-30       Impact factor: 2.571

6.  Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases.

Authors:  Marine Fauny; Nicolas Cohen; Caroline Morizot; Sophie Leclerc-Jacob; Daniel Wendling; Guillaume Lux; Valérie Laurent; Alain Blum; Patrick Netter; Cédric Baumann; Isabelle Chary-Valckenaere; Laurent Peyrin-Biroulet; Damien Loeuille
Journal:  Inflamm Intest Dis       Date:  2020-06-03

Review 7.  Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

8.  Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease.

Authors:  O A Saatci; N Koçak; I Durak; M H Ergin
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

9.  A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations.

Authors:  Cristina Costa Duarte Lanna; Maria de Lourdes Abreu Ferrari; Sidney Lemos Rocha; Evaldo Nascimento; Marco Antônio Parreiras de Carvalho; Aloísio Sales da Cunha
Journal:  Clin Rheumatol       Date:  2007-12-21       Impact factor: 2.980

10.  Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study.

Authors:  Tzu-Chen Lo; Yu-Yen Chen; Hsin-Hua Chen
Journal:  Eye (Lond)       Date:  2021-06-21       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.